Safety and Efficacy of Biosimilars and Generic DMTs

Sponsored by Sandoz

11 Nov 2024 | ~2:13 Engagement Time

Featuring

Kristin Galetta , Neurologist and MS Specialist

On This Page

Related Resources

Special Webinar - Generics and Biosimilars: Sorting out Fact From Fiction Thumbnail

Generics and Biosimilars: Sorting out Fact From Fiction

Roz Kalb , Psychologist , Nancy Sicotte , Neurologist & Bari Talente , EVP, Advocacy and Healthcare Access, NMSS

Biosimilar Medications and MS: What You Need To Know

Derrick Robertson , Neurologist & Stephanie Buxhoeveden , PhD, MSCN, MSN, FNP-BC

Video

Dr. Kristin Galetta sitting in her office.

Overview

The most common question about biosimilars and generic medications is – are they as effective?  The answer is yes; these medications are just as safe and effective as the biologic or name-brand equivalent. Neurologist and MS specialist Dr. Kristin Galetta breaks down how these medications are effective in treating MS and how they are helping to broaden DMT access.

Thank you to our generous sponsor for making this content possible, Sandoz.